Position SummaryThe Director / Sr. Director, Pharmacovigilance & Drug Safety serves as Ocugen's head of pharmacovigilance and lead safety physician across the company's clinical-stage portfolio of ocular gene therapies, including OCU400 (retinitis pigmentosa), OCU410 (geographic atrophy), and OCU410ST (Stargardt disease). The incumbent provides medical leadership and operational accountability for the global PV system—ICSR management, signal detection, benefit–risk evaluation, aggregate safety reporting, vendor oversight, and inspection readiness—with particular focus on the distinct safety considerations of subretinal and intravitreal administration, AAV-related immunogenicity, and long-term follow-up under FDA CBER guidance.As a leader within a publicly traded biotechnology company, this role also supports timely and accurate safety input to executive leadership, the Board of Directors, and external disclosures. The position partners closely with Clinical Development, Reg...